✦ LIBER ✦

7105 Phase II trial of the oral multikinase inhibitor BAY 73–4506 as 1st-line therapy in patients with metastatic or unresectable renal cell cancer (RCC)

✍ Scribed by Eisen, T.; Joensuu, H.; Nathan, P.; Harper, P.; Wojtukiewicz, M.; Nicholson, S.; Bahl, A.; Tomczak, P.; Wagner, A.; Quinn, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7141 POSTER Phase II Trial of the Oral M

✍ Eisen, T.; Joensuu, H.; Nathan, P.; Harper, P.; Wojtukiewicz, M.; Nicholson, S.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

6576 POSTER Phase II Safety Study of the

✍ Bolondi, L.; Tak, W.Y.; Gasbarrini, A.; Santoro, A.; Colombo, M.; Lim, H.Y.; Maz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Re: Phase II Trial of Sorafenib Plus Int

✍ Fray F. Marshall 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A phase II trial of a selective c-Met in

✍ Kang, Yoon-Koo; Muro, Kei; Ryu, Min-Hee; Yasui, Hirofumi; Nishina, Tomohiro; Ryo 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 234 KB